Troels Johansen is a biomedical engineer and PhD specialized in the bioengineering and physiology of CO2 and oxygen.
He invented Rehaler’s technological concept and directed the technical development and exploratory clinical studies that led to the current CE-approved device.
In the course of his PhD work at Aarhus University Hospital and Harvard Medical School he developed the world’s first method for 3D imaging of pulmonary gas transfer, alongside his ongoing work on the Rehaler technology.
He holds the position of Senior Teaching Fellow at Biomedical Design Novo Nordisk Foundation Fellowship Programme, a medtech innovation and entrepreneurship programme at Aarhus and Copenhagen Universities.
Chairman of the Board
Thomas Feldthus (M.Sc., MBA) is an experienced entrepreneur with extensive management experience in the biotech industry.
Co-founder of Saniona, Scandion Oncology, Initiator Pharma, Symphogen, Ataxion and Leukotech.
Previously served as vVD and CFO of Saniona.
Prior to that CFO of Symphogen, Corporate Development Manager at Novo Nordisk and Investment Associate at Novo A/S.
Currently serves on the boards of Rehaler, Scandion Oncology and ResoTher Pharma.